Plasma amino-terminal pro-B-type natriuretic peptide quantification in hypertrophic cardiomyopathy

American Heart Journal

Volumn 150, Issue 6, 2005, Pages 1228-1232

  Arteaga, Edmundo ^a,b   Araujo, Aloir Queiroz ^a   Buck, Paula ^a   Ianni, Barbara Maria ^a   Rabello, Rogerio ^a   Mady, Charles ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART LEFT ATRIUM; HEART LEFT VENTRICLE FAILURE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; M MODE ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANK SUM TEST; SYMPTOMATOLOGY;

ADULT; BIOLOGICAL MARKERS; CARDIOMYOPATHY, HYPERTROPHIC; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIA; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; REFERENCE VALUES;

EID: 28844462472     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2005.02.045     Document Type: Article

References (21)

1. P. Richardson, W. McKenna, and M. Bristow Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies Circulation 93 1996 841 842
2. A.J. Marian Pathogenesis of diverse clinical and pathological phenotypes in hypertrophic cardiomyopathy Lancet 355 2000 58 60
3. C. Briguori, S. Betocchi, and M. Romano Exercise capacity in hypertrophic cardiomyopathy depends on left ventricular diastolic function Am J Cardiol 84 1999 309 315
4. B.J. Maron Hypertrophic cardiomyopathy. A systematic review JAMA 287 2002 1308 1320
5. A.S. Maisel, and P.A. McCullough Cardiac natriuretic peptides: a proteomic window to cardiac function and clinical management Rev Cardiovasc Med 4 Suppl 4 2003 S3 S12
6. E. Lubien, A. DeMaria, and P. Krishnaswamy Utility of B-natriuretic peptide in detecting diastolic dysfunction. Comparison with Doppler velocity recordings Circulation 105 2002 595 601
7. K. Nishigaki, M. Tomita, and K. Kagawa Marked expression of plasma brain natriuretic peptide is a special feature of hypertrophic obstructive cardiomyopathy J Am Coll Cardiol 28 1996 1234 1242
8. C. Briguori, S. Betocchi, and F. Manganelli Determinants and clinical significance of natriuretic peptides in hypertrophic cardiomyopathy Eur Heart J 22 2001 1328 1336
9. D. Hughes, S. Talwar, and I.B. Squire An immunoluminometric assay for N-terminal pro-brain natriuretic peptide: development of a test for left ventricular dysfunction Clin Sci 96 1999 373 380
10. D.J. Campbell, K.I. Mitchelhill, and S.M. Schlicht Plasma amino-terminal pro-brain natriuretic peptide: a novel approach to the diagnosis of cardiac dysfunction J Card Fail 2 2000 130 139
11. D.J. Sahn, A. DeMaria, and J. Kisslo Recommendations regarding quantification in M-mode echocardiography: results of a survey of echocardiographic measurements Circulation 58 1978 1072 1083
12. H. Rakowski, C. Appleton, and K. Chan Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography J Am Soc Echocardiogr 9 1996 736 760
13. S.F. Nagueh, N.M. Lakkis, and K.J. Middleton Doppler estimation of left ventricular filling pressures in patients with hypertrophic cardiomyopathy Circulation 99 1999 254 261
14. C. Hall Essential biochemistry and physiology of (NT-pro) BNP Eur J Heart Fail 6 2004 257 260
15. K.T. Yeo, A.H. Wu, and F.S. Apple Multicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay Clin Chim Acta 338 2003 107 115
16. S. Masson, T. Vago, and G. Baldi Comparative measurement of N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in ambulatory patients with heart failure Clin Chem Lab Med 40 2002 761 763
17. J.G. Lainchbury, E. Campbell, and C.M. Frampton Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with shortness of breath J Am Coll Cardiol 42 2003 728 735
18. R. Pfister, M. Scholz, and K. Wielckens Use of NT-proBNP test in routine testing and comparison to BNP Eur J Heart Fail 6 2004 289 293
19. K. Hasegawa, H. Fujiwara, and K. Doyama Ventricular expression of brain natriuretic peptide in hypertrophic cardiomyopathy Circulation 88 1993 372 380
20. T. Nakamura, K. Sakamoto, and T. Yamano Increased plasma brain natriuretic peptide levels as a guide for silent myocardial ischemia in patients with non-obstructive hypertrophic cardiomyopathy J Am Coll Cardiol 39 2002 1657 1663
21. B.J. Maron, N. Venkatakrishna, and V.N. Tholakanahalli Usefulness of B-type natriuretic peptide assay in the assessment of symptomatic state in hypertrophic cardiomyopathy Circulation 109 2004 984 989